A study on the interaction between macromolecules such as tyrosine kinase and small molecules
A study on the interaction between macromolecules such as tyrosine kinase and small molecules
批准号:
15590474
负责人:
AKAHO Eiichi
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We synthesized indole derivatives, and investigated the inhibition activity against protein tyrosine kinase (p60 c-Src). As a result, it was found that Compound 4 showed the strongest inhibition activity representing 1.34 μM IC_<50>. When we investigated the interaction between Compound 4 and the enzyme active site, it was shown that the strong interaction was exhibited between Compound 4 and the Lis 295 which is said to play an important role in the active site. We also synthesized 3-(substituted-benzylidene)-1,3-dihydro-indolin derivatives, and investigated the interaction between the synthesized derivatives and protein tyrosine kinase (p60 c-Src). It was found that inhibitory IC_<50> of Compound 12, 19. 13 represented 21.91, 21.20, 30.92 μM, respectively. These values are considered to be fairly well, although they are not in the best range. As for the docking simulation of those compounds, Compound 8, and 16 showed the strong affinity against the active site of the enzyme. Malaysian plant extract, Acalypha siamensis Olive. Ex Gage was obtained from collaborative researcher, and isolated each ingredient and the structure determination was performed by analytical instrument such as NMR, MS and so on. It was indicated that innovative compounds, Acalyphaser existed as chiral form of R, R, S or S, S, R. Docking simulation study between those compounds and protein tyrosine kinase (p60 c-Src) represented binding free energy of -5.97 kal/mol, and some showed the hydrogen bond against Hia58. It was extrapolated that IC_<50> values against human T-cell acute lymphoblastic leukemia (CCRF-HSB-2) and human oral epithermal carcinoma (KB) was 0.72 1.42 μM and 1.42 μM respectively.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
2003
期刊:
YAKUGAKU ZASSHI 123(3)
影响因子:
--
作者:
[Eiichi AKAHO, Masako UCHINASHI, Akiko TSURUSAWA, Junko TOMINAGA, Shinichi HAYASHI]
通讯作者:
Shinichi HAYASHI
Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1,3-dihydro-indolin derivatives : investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies
3-(取代-亚苄基)-1,3-二氢吲哚啉衍生物的合成和抗酪氨酸激酶活性:应用受体对接研究研究其对p60c-Src受体酪氨酸激酶的作用
DOI:
--
发表时间:
2005
期刊:
Il Farmaco 60
影响因子:
--
作者:
[Sureyya Olgen, Eiichi Akaho, Dogu Nebioglu]
通讯作者:
Dogu Nebioglu
A study on the Interaction between p60c-Src Receptor Tyrosine Kinase and Arylcarboxylic and Arlacetic Acid Derivatives Based on Docking Modes and in vitro Activity
基于对接模式和体外活性的p60c-Src受体酪氨酸激酶与芳基羧酸和芳基乙酸衍生物相互作用的研究
DOI:
--
发表时间:
2004
期刊:
Biol.Pharm.Bull. 27(1)
影响因子:
--
作者:
[Gul Altuntas, Sureyya Olgen, Dogu Nebioglu, Eiichi Akaho]
通讯作者:
Eiichi Akaho
Evidence-based practice characterized by number needed to treat as pharmacist's basic responsibility
循证实践的特点是需要将数量视为药剂师的基本职责
DOI:
--
发表时间:
2006
期刊:
Japan.J.Drug Inf. 27(4)
影响因子:
--
作者:
[Eiichi AKAHO, Mitsuko HIRAI, Michael D.KATZ, Chisae UMEZAWA]
通讯作者:
Chisae UMEZAWA
Enhancing pharmacacist's status through collaborative prescription prescribing : US and Japan perspective
通过协作处方提高药剂师的地位:美国和日本的观点
DOI:
--
发表时间:
2005
期刊:
Jpn J Health Care Sci 31(11
影响因子:
--
作者:
[E Akaho, S Brouse, H Kambara, K Kawasaki]
通讯作者:
K Kawasaki
共 22 条
A study on innovative computer simulation for drug design
-
批准号:11695096
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1999
-
负责人:AKAHO Eiichi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
-
批准号:82370797
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陶弢
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
骨骼肌中胰高血糖素受体的表达及其调控血糖稳态的作用与机制研究
-
批准号:82370820
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王天歌
-
依托单位:
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
-
批准号:82371007
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:雷浪
-
依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:傅强
-
依托单位:
拟南芥中水杨酸介导花粉管生长的受体筛选及其分子机理研究
-
批准号:32100576
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:荣朵艳
-
依托单位:
Nek9磷酸化MCL-1调控线粒体自噬和分裂的机制与功能研究
-
批准号:32100598
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:岑旭峰
-
依托单位:
褪黑素促进MCL-1抑制剂诱导白血病细胞凋亡的分子机制研究
-
批准号:32100607
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:叶开琴
-
依托单位: